Commonwealth Equity Services’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30K | Sell |
21,111
-4,989
| -19% | -$7.09K | ﹤0.01% | 4200 |
|
2025
Q1 | $42K | Sell |
26,100
-2,780
| -10% | -$4.47K | ﹤0.01% | 4081 |
|
2024
Q4 | $104K | Sell |
28,880
-6,290
| -18% | -$22.7K | ﹤0.01% | 3897 |
|
2024
Q3 | $200K | Sell |
35,170
-2,927
| -8% | -$16.6K | ﹤0.01% | 3703 |
|
2024
Q2 | $176K | Sell |
38,097
-905
| -2% | -$4.18K | ﹤0.01% | 3678 |
|
2024
Q1 | $319K | Buy |
39,002
+22,692
| +139% | +$186K | ﹤0.01% | 3218 |
|
2023
Q4 | $92K | Buy |
16,310
+839
| +5% | +$4.73K | ﹤0.01% | 3685 |
|
2023
Q3 | $29K | Buy |
15,471
+61
| +0.4% | +$114 | ﹤0.01% | 3707 |
|
2023
Q2 | $42K | Hold |
15,410
| – | – | ﹤0.01% | 3684 |
|
2023
Q1 | $48 | Buy |
15,410
+1,212
| +9% | +$4 | ﹤0.01% | 3584 |
|
2022
Q4 | $83K | Buy |
14,198
+305
| +2% | +$1.78K | ﹤0.01% | 3443 |
|
2022
Q3 | $121K | Sell |
13,893
-817
| -6% | -$7.12K | ﹤0.01% | 3328 |
|
2022
Q2 | $110K | Buy |
+14,710
| New | +$110K | ﹤0.01% | 3349 |
|